It is known that insulin via its receptor (IR) can perform metabolic activities through PI3K/Akt pathways in stem cells or cancer stem cells [22, 25], we therefore hypothesised that insulin could directly involve in regulating PD-L1 expression or production through PI3K/Akt pathways during the enrichment of CSCs in tumour sphere culture. The gene discussed is AKT1; the disease is cancer.